UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From STEM to STEAM: Towards aerospace partnerships with cultural heritage diagnostics

2014 IEEE Aerospace Conference, 2014, p.1-11

2014

Volltextzugriff (PDF)

On the Alert for Cytokine Storm: Immunopathology in COVID‐19

Arthritis & rheumatology (Hoboken, N.J.), 2020-07, Vol.72 (7), p.1059-1063

2020

Volltextzugriff (PDF)

Criteria for Cytokine Storm Syndromes

Advances in experimental medicine and biology, 2024, Vol.1448, p.59

2024

Volltextzugriff (PDF)

Macrophage Activation Syndrome

Hematology/oncology clinics of North America, 2015-10, Vol.29 (5), p.927-941

2015

Volltextzugriff (PDF)

USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression

Cancer research (Chicago, Ill.), 2014-01, Vol.74 (1), p.272-286

2014

Volltextzugriff (PDF)

Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell‐ and Tissue‐Based Therapies: Concise Review

Stem cells translational medicine, 2019-12, Vol.8 (12), p.1265-1271

2019

Volltextzugriff (PDF)

An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis

Journal of rheumatology, 2011-04, Vol.38 (4), p.764-768

2011

Volltextzugriff (PDF)

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion

The Journal of clinical investigation, 2020-05, Vol.130 (5), p.2270-2285

2020

Volltextzugriff (PDF)

HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation

The New England journal of medicine, 2024-02, Vol.390 (7), p.669-671

2024

Volltextzugriff (PDF)

Clinical features and correct diagnosis of macrophage activation syndrome

Expert review of clinical immunology, 2015-09, Vol.11 (9), p.1043-1053

2015

Volltextzugriff (PDF)

Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load

Cell reports (Cambridge), 2024-06, Vol.43 (6), p.114311-114311, Article 114311

2024

Volltextzugriff (PDF)

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis

Arthritis care & research (2010), 2018-03, Vol.70 (3), p.409-419

2018

Volltextzugriff (PDF)

Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas

The New England journal of medicine, 2020-08, Vol.383 (8), p.733-742

2020

Volltextzugriff (PDF)

Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

ACR open rheumatology, 2019-08, Vol.1 (6), p.345-349

2019

Volltextzugriff (PDF)

Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1357-1362

2019

Volltextzugriff (PDF)

Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients

The Journal of pediatrics, 2021-08, Vol.235, p.196-202

2021

Volltextzugriff (PDF)

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4110-4116

2005

Volltextzugriff (PDF)

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Arthritis & rheumatology (Hoboken, N.J.), 2014-11, Vol.66 (11), p.3160-3169

2014

Volltextzugriff (PDF)

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Arthritis & rheumatology (Hoboken, N.J.), 2023-10, Vol.75 (10), p.1714-1732

2023

Volltextzugriff (PDF)

Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3

Blood, 2023-11, Vol.142 (Supplement 1), p.3357-3357

2023

Volltextzugriff (PDF)

Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative

Journal of the American College of Surgeons, 2018-05, Vol.226 (5), p.814-824

2018

Volltextzugriff (PDF)

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2014-10, Vol.66 (10), p.2871-2880

2014

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(84)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Humans
(29)
Male
(18)
Female
(14)
Adult
(12)
Child
(12)
Rheumatology
(11)
Macrophage Activation Syndrome
(9)
Macrophage Activation Syndrome - Diagnosis
(9)
Animals
(8)
Laboratories
(8)
Medicin Och Hälsovetenskap
(8)
Systemic Juvenile Idiopathic Arthritis
(8)
Biological And Medical Sciences
(7)
Child, Preschool
(7)
Hemophagocytic Lymphohistiocytosis
(7)
Medical Sciences
(7)
Oncology
(7)
Patients
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From STEM to STEAM: Towards aerospace partnerships with cultural heritage diagnostics

On the Alert for Cytokine Storm: Immunopathology in COVID‐19

Criteria for Cytokine Storm Syndromes

Macrophage Activation Syndrome

USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression

Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell‐ and Tissue‐Based Therapies: Concise Review

An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion

HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation

Clinical features and correct diagnosis of macrophage activation syndrome

Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis

Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas

The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)

Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Diagnostic Guidelines for Familial Hemophagocytic Lymphohistiocytosis Revisited

Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3

Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Suchergebnisse filtern